Neuro-Oncology

Published by: Oxford University Press  

People

  1. De Angelis
    De Angelis
  2. Dunkel
    Dunkel
  3. Mellinghoff
    Mellinghoff
  4. Karajannis
    Karajannis
  5. Kaley
    Kaley
  6. Souweidane
    Souweidane
  7. Khakoo
    Khakoo
  8. Pentsova
    Pentsova
  9. Kramer
    Kramer
  10. Panageas
    Panageas

Groups

  1. Tow Center for Developmental Oncology (TCDO) (217)
  2. Pediatrics, Department of (211)
  3. GSK Faculty (206)
  4. Neuro-Oncology Service (159)
  5. Survivorship Research (136)
  6. Human Oncology and Pathogenesis Program (112)
  7. Radiology, Department of (111)
  8. Neuroradiology Service (87)
  9. Department of Medicine (85)
  10. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (82)
Search Within
Formats
  1. Meeting Abstract (612)
  2. Journal Article (142)
  3. Editorial (11)
  4. Review (9)
  5. Guidelines (5)
  6. Correspondence (1)
  7. Research Letter (1)
Groups
  1. Tow Center for Developmental Oncology (TCDO) (217)
  2. Pediatrics, Department of (211)
  3. GSK Faculty (206)
  4. Neuro-Oncology Service (159)
  5. Survivorship Research (136)
  6. Human Oncology and Pathogenesis Program (112)

More Groups

People
  1. Lisa De Angelis (107)
  2. Ira Dunkel (75)
  3. Ingo Mellinghoff (67)
  4. Antonio Omuro (63)
  5. Lauren Abrey (63)
  6. Matthias Karajannis (56)

More People

Years
  1. 2024 (2)
  2. 2023 (53)
  3. 2022 (63)
  4. 2021 (35)
  5. 2020 (66)
  6. 2019 (58)

More Years

Publishers
  1. Oxford University Press (781)

Results (781)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Large-volume low apparent diffusion coefficient lesions predict poor survival in bevacizumab-treated glioblastoma patients
    Journal Article

    Zhang, M.; Gulotta, B.; Thomas, A.; Kaley, T.; Karimi, S.; Gavrilovic, I.; Woo, K. M.; Zhang, Z.; Arevalo-Perez, J.; Holodny, A. I.; more...
    Neuro-Oncology (2016)

    Fulltext@MSK | Save
  • Rates and risks for late referral to hospice in patients with primary malignant brain tumors
    Journal Article

    Diamond, E. L.; Russell, D.; Kryza-Lacombe, M.; Bowles, K. H.; Applebaum, A. J.; Dennis, J.; Deangelis, L. M.; Prigerson, H. G.
    Neuro-Oncology (2016)

    Fulltext@MSK | Save
  • Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma
    Journal Article

    de la Fuente, M. I.; Young, R. J.; Rubel, J.; Rosenblum, M.; Tisnado, J.; Briggs, S.; Arevalo-Perez, J.; Cross, J. R.; Campos, C.; Straley, K.; more...
    Neuro-Oncology (2016)

    Fulltext@MSK | Save
  • Clinical course and progression-free survival of adult intracranial and spinal ependymoma patients
    Journal Article

    Vera-Bolanos, E.; Aldape, K.; Yuan, Y.; Wu, J.; Wani, K.; Necesito-Reyes, M. J.; Colman, H.; Dhall, G.; Lieberman, F. S.; Metellus, P.; more...
    Neuro-Oncology (2015)

    Fulltext@MSK | Save
  • Clinical implementation of integrated whole-genome copy number and mutation profiling for glioblastoma
    Journal Article

    Ramkissoon, S. H.; Bi, W. L.; Schumacher, S. E.; Ramkissoon, L. A.; Haidar, S.; Knoff, D.; Dubuc, A.; Brown, L.; Burns, M.; Cryan, J. B.; more...
    Neuro-Oncology (2015)

    Fulltext@MSK | Save
  • Detection of K27m mutant pediatric glioblastomas by immunohistochemistry
    Meeting Abstract

    Venneti, S.; Santi, M.; Felicella, M. M.; Yarilin, D.; Phillips, J.; Sullivan, L.; Martinez, D.; Perry, A.; Lewis, P.; Thompson, C.; more...
    Neuro-Oncology (2015)

    Fulltext@MSK | Save
  • Toward precision medicine in glioblastoma: The promise and the challenges
    Journal Article

    Prados, M. D.; Byron, S. A.; Tran, N. L.; Phillips, J. J.; Molinaro, A. M.; Ligon, K. L.; Wen, P. Y.; Kuhn, J. G.; Mellinghoff, I. K.; De Groot, J. F.; more...
    Neuro-Oncology (2015)

    Fulltext@MSK | Save
  • A phase I study of cediranib in combination with cilengitide in patients with recurrent glioblastoma
    Journal Article

    Gerstner, E. R.; Ye, X.; Duda, D. G.; Levine, M. A.; Mikkelsen, T.; Kaley, T. J.; Olson, J. J.; Nabors, B. L.; Ahluwalia, M. S.; Wen, P. Y.; more...
    Neuro-Oncology (2015)

    Fulltext@MSK | Save
  • Somatic POLE mutations cause an ultramutated giant cell high-grade glioma subtype with better prognosis
    Journal Article

    Erson-Omay, E. Z.; Cąʇlayan, A. O.; Schultz, N.; Weinhold, N.; Omay, S. B.; Özduman, K.; Köksal, Y.; Li, J.; Serin Harmancl, A.; Clark, V.; more...
    Neuro-Oncology (2015)

    Fulltext@MSK | Save
  • Phase I dose-escalation study of the PI3K/mTOR inhibitor voxtalisib (SAR245409, XL765) plus temozolomide with or without radiotherapy in patients with high-grade glioma
    Journal Article

    Wen, P. Y.; Omuro, A.; Ahluwalia, M. S.; Fathallah-Shaykh, H. M.; Mohile, N.; Lager, J. J.; Laird, A. D.; Tang, J.; Jiang, J.; Egile, C.; more...
    Neuro-Oncology (2015)

    Fulltext@MSK | Save

    • Neuro-Oncology – authorized name for:

    Name ISSN / ISBN Publisher
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press On Behalf of the Society for Neuro Oncology
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-oncology 15235866 Unknown
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 15228517 The Author(s)
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 15228517 Oxford University Press On Behalf of the Society for Neuro Oncology
    Neuro-Oncology 1522-8517 Carden Jennings Publ Co Ltd
    Neuro-Oncology 1522-8517 Duke University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 15228517 Unknown
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 15228517 The Author(s) 2023
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-oncology 15235866 Oxford University Press On Behalf of the Society for Neuro Oncology
    Neuro-Oncology 1522-8517 Duke University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1523-5866 Oxford University Press On Behalf of the Society for Neuro Oncology
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Society for Neuro Oncology